Spotlighting undiscovered companies with enormous upside potential.
Contact us:
(512) 354-7000
Spotlighting undiscovered companies with enormous upside potential.
Home
About
Tiny Gems
NewsRoom
Newsletter Archives
Events
Contact
Headlines
GridAI Technologies Corp. (GRDX) Names Marshall Chapin as the CEO for AI and Energy Infrastructure Subsidiary, GridAI, Inc.
Safe Pro Group Inc. (SPAI) Showed off New High-Performance Body Armor Plates and Ballistic Shield at SHOT Show 2026
ParaZero Technologies Ltd. (PRZO) Expands Counter-UAS Capabilities and Strengthens in Modern Defense
How Bitcoin is Already Being Impacted by Quantum Computing
Novel Therapy Helps Tumor Cells Welcome Cancer Treatment
Home
/
NewsRoom
TinyGemsBreaks
Headline
Company of Focus
Date
TinyGemsBreaks – Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Completes $4.3B Antamina Silver Stream Deal With BHP
Wheaton Precious Metals Corp. (WPM)
April 2, 2026
TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Reports 2025 Results, Highlights Revenue Growth and Global Expansion
Rail Vision Ltd. (RVSN)
April 1, 2026
TinyGemsBreaks – Frontieras North America to Livestream April 2 Groundbreaking for First Commercial FASForm(TM) Plant
Frontieras North America
March 31, 2026
TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Appoints Veloce Executives To Drive Growth Strategy
SEGG Media Corporation (SEGG)
March 30, 2026
TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Reports 2025 Results, Targets Triple-Digit Growth In 2026
Knightscope Inc. (KSCP)
March 30, 2026
View All TinyGemsBreaks
TinyGems Articles
Headline
Company of Focus
Date
Researchers Solve 50-Year-Old Challenge in Making Cancer Drug
CNS Pharmaceuticals, Inc. (CNSP)
April 1, 2026
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes
Lixte Biotechnology Holdings, Inc. (LIXT)
March 31, 2026
Research Suggests the Thymus is Critical in Immunotherapy Outcomes
Calidi Biotherapeutics Inc. (CLDI)
March 30, 2026
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials
Lixte Biotechnology Holdings, Inc. (LIXT)
March 30, 2026
Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership
Lixte Biotechnology Holdings, Inc. (LIXT)
March 26, 2026
View All Articles
Public Press Releases
Filter Releases
Sectors
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More Articles
Contact us:
(512) 354-7000